LYO-X | New publication with the contribution of LYO-X on a population pharmacokinetic model that describes cefepime (FEP) and enmetazobactam (ENM) plasma PK in adult cUTI/ AP patients

back to News archive

New publication with the contribution of LYO-X on a population pharmacokinetic model that describes cefepime (FEP) and enmetazobactam (ENM) plasma PK in adult cUTI/ AP patients

27 November, 2023

_